SuperworthProcter & Gamble PG
- Market cap
- $374.3B
- PE
- 24.3×
- 10y median 25.2×
- Forward PE
- 23.3×
- 10y median 23.7×
- Price to sales
- 4.3×
- EV/EBIT
- 20.1×
- Revenue, 12 months
- $87.9B
- +4% on a year ago
- Net margin
- 18.2%
- Free cash flow yield
- n/m
- Q1 FY27 missing
Procter & Gamble trades at 24.3× trailing earnings, near its ten-year median. Revenue was $87.9B over the last twelve months, up 4% on a year earlier with a 18% net margin.
Charts
Financials
| Income statement | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $21.4B+3% | $20.2B+1% | $20.5B−0% | $21.7B−1% | $21.9B+2% | $19.8B−2% | $20.9B+2% | $22.4B+3% | $22.2B+2% | $21.2B+7% | $21.2B+2% | $23.3B+4% | |
| Cost of revenue | $10.1B−7% | $9.9B−5% | $10.3B−3% | $10.4B−1% | $10.4B+3% | $9.7B−2% | $10.6B+3% | $10.9B+5% | $10.8B+4% | $10.7B+11% | $10.9B+3% | $11.7B+7% |
| Gross profit | $11.3B+14% | $10.3B+7% | $10.2B+3% | $11.3B−1% | $11.5B+2% | $10.1B−3% | $10.3B+1% | $11.5B+2% | $11.4B−1% | $10.5B+4% | $10.3B+0% | n/a |
| SG&A | $5.5B+9% | $5.9B+9% | $6.3B+9% | $5.5B−2% | $5.7B+4% | $5.5B−6% | $5.9B−6% | $5.6B+2% | $6B+5% | $5.9B+8% | $6.3B+7% | $5.7B+0% |
| $4.4B−7% | $4.5B+5% | $3.9B−7% | $5.8B+1% | $5.7B+30% | $4.6B+2% | $4.4B+12% | $5.9B+1% | $5.4B−7% | $4.6B+0% | $4B−9% | $5.9B+1% | |
| Interest expense | $248M+45% | $233M+5% | $220M−8% | $238M+6% | $240M−3% | $217M−7% | $212M−4% | $197M−17% | $220M−8% | $223M+3% | $236M+11% | n/a |
| Pre-tax income | $4.5B−7% | $4.6B+7% | $3.9B−9% | $5.1B−11% | $5.8B+30% | $4.7B+2% | $4.5B+17% | $6B+17% | $5.4B−7% | $5B+7% | $3.9B−13% | $6B−0% |
| $1B+15% | $812M−6% | $726M−14% | $1.2B−8% | $1.2B+18% | $868M+7% | $895M+23% | $1.3B+9% | $1.1B−8% | $1B+20% | $852M−5% | $1.3B+1% | |
| Net income | $3.5B−12% | $3.8B+11% | $3.1B−7% | $4B−12% | $4.6B+34% | $3.8B+0% | $3.6B+15% | $4.8B+20% | $4.3B−7% | $3.9B+4% | $3B−16% | $4.7B−0% |
| $1.40−12% | $1.52+11% | $1.27−7% | $1.61−12% | $1.88+34% | $1.54+1% | $1.48+17% | $1.95+21% | $1.78−5% | $1.63+6% | $1.26−15% | $1.97+1% | |
| 2.5B−1% | 2.5B+0% | 2.5B−0% | 2.5B−0% | 2.5B−0% | 2.4B−1% | 2.4B−1% | 2.4B−1% | 2.4B−1% | 2.4B−1% | 2.4B−1% | 2.4B−1% |
Gross profit: 72 periods, Q1 FY09 to Q4 FY26: not printed by the filing, worked out from its own lines.
Net income: 6 periods, Q4 FY21 to Q4 FY26: printed in the fourth-quarter results release.
EPS, diluted: Q4 FY14: quarter's net income to common over its shares, to the cent. 6 periods, Q4 FY21 to Q4 FY26: printed in the fourth-quarter results release.
Diluted shares: 6 periods, Q4 FY14 to Q4 FY20: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY19: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 6 periods, Q4 FY21 to Q4 FY26: printed in the fourth-quarter results release.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet. Figures from older filings without data tags, and from a results release before its 10-Q, are read from the document's text and checked against it.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q2 FY27 | $22.8B | $22.5B to $23B | $1.83 | $1.79 to $1.88 | 14 |
| Q3 FY27 | $21.8B | $21.3B to $22.1B | $1.64 | $1.59 to $1.69 | 18 |
| Q4 FY27 | $22B | $21.7B to $22.3B | $1.55 | $1.52 to $1.57 | 8 |
| Q1 FY28 | $23.8B | $23.5B to $24.2B | $2.08 | $2.04 to $2.12 | 12 |
| Q2 FY28 | $23.4B | $23.1B to $23.7B | $1.96 | $1.92 to $1.99 | 8 |
| Q3 FY28 | $22.4B | $22B to $22.7B | $1.74 | $1.70 to $1.77 | 17 |
| Q4 FY28 | $22.7B | $22.3B to $23B | $1.63 | $1.60 to $1.66 | 11 |
| Q1 FY29 | $24.5B | $24.1B to $24.9B | $2.09 | $2.05 to $2.13 | 9 |
Peers
Companies in Household & Personal Products nearest Procter & Gamble's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| PGProcter & Gamble | $374.3B | 24.3× | 25.2× | 23.3× | 4.3× | +4% | 18.2% |
| CLColgate-Palmolive | $75B | 37.3× | 27.2× | 24.0× | 3.6× | +5% | 9.7% |
| ELEstée Lauder Companies | $39.3B | 222× | 44.6× | 32.8× | 2.6× | +5% | 1.2% |
| KVUEKenvue | $37.6B | 22.5× | 24.1× | 16.2× | 2.4× | +2% | 10.8% |
| Peer median | $39.3B | 37.3× | 27.2× | 24.0× | 2.6× | +5% | 9.7% |
Investors who own it
Investors we follow who held Procter & Gamble at the end of Jun 30, 2026, from their 13F filings.
- Terry SmithFundsmith4.4% of portfoliotrimmed
- Baillie GiffordBaillie Gifford0.1% of portfoliotrimmed
- Tom RussoGardner Russo & Quinn0.0% of portfoliotrimmed
- Bill NygrenHarris Associates (Oakmark)0.0% of portfolio
More on Procter & Gamble
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 15Household and personal products stocks with the highest profit margins
- #10of 127Consumer staples stocks with the highest profit margins
- #7of 15Household and personal products stocks with the fastest revenue growth
- #7of 11Household and personal products stocks with the lowest PE ratio
- #10of 15Household and personal products stocks with the lowest EV/EBIT
- #7of 10Household and personal products stocks with the fastest earnings growth
Its groups
About
- Chief executive
- Shailesh Jejurikar, since 2026Joined 1989, CEO since January 2026. Source
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .